
Authors & Contributors
The cost of healthcare remains a significant challenge, but we believe that innovative treatments, such as viral and cell-based gene therapies, have the potential to transform patient treatment and the healthcare industry at large. These therapies come at steep initial price points but, over the long term, may lower a patient’s lifetime cost of care.
Related
Insights
COVID-19
Fighting COVID-19 with Gene Technology
Manager Insights | COVID-19 | Article | Thematic | Equity
Read

Manager Insights
The Cutting Edge: Gene Editing
Manager Insights | Article | Thematic | Equity
Read

Double Take podcast
Episode 3: Gene Therapy: Cures, Risks and Opportunities
Double Take podcast | Audio | Thematic | Equity
Listen
